BLSM:NASDAQ, BlossomHill Therapeutics Inc.

BLSM stock overview

BlossomHill Therapeutics Inc. (BLSM:NASDAQ) closed at $13.50 on November 6, 2026, up 9.31% on the day. The stock trades 51.8% below its 52-week high of $27.99 and 22.5% above its 52-week low of $11.02. Over the past year, it lost 15.6%. BlossomHill Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$13.50
Day change
+9.31%
Volume
174,332
Average volume
227,401
Market cap
429M+
52-week range
$11.02 – $27.99
50-day average
$18.58
200-day average
$18.13

Price action over the past year

In 64 trading sessions since August 10, 2026, BLSM closed higher on 31 days (48%). Its best day was September 16, 2026 (+18.40%) and its worst was October 6, 2026 (-13.29%). The stock moved 10% or more in a single session 7 times.

Recent signals

BLSM news

About BlossomHill Therapeutics Inc.

BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines that address significant unmet medical needs in cancer treatment. Founded and led by industry veteran J. Jean Cui, Ph.D., with her proven track record in oncology drug design and development - including three FDA-approved drugs - BlossomHill Therapeutics applies cutting-edge science to address key oncogenic drivers and improve patient outcomes in difficult-to-treat cancers.

Similar stocks

Find more stocks like BLSM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.